ProtaMed, Inc.

SYNUCLERE

Pharmaceutical preparations for the prevention of synucleinopathies including Lewy Body disease and Parkinson's disease; Pharmaceutical preparations for the treatment of synucleinopathies including Lewy Body disease and Parkinson's disease;

SYSTEBRYL

Pharmaceutical preparations for the prevention of systemic amyloid diseases; Pharmaceutical preparations for the treatment of systemic amyloid diseases;

TAUPRO

Chemical preparations for pharmaceutical or medical purposes, namely, for treatment of tauopathies; Pharmaceutical agents affecting metabolism; Pharmaceutical agents affecting peripheral nervous system; Pharmaceutical agents affecting sensory organs; Pharmaceutical preparations acting on the central nervous system; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Pharmaceutical preparations for peripheral nervous system; Pharmaceutical preparations for the prevention and treatment of disorders of the nervous system, the immune system, the cardio-vascular system, the metabolic system, the respiratory system, the musculo-skeletal system, the genitourinary system; for the treatment of inflammatory disorders; for use in dermatology, oncology, hematology and in tissue and organ transplantation, in ophthalmology and for gastroenterological disorders; Pharmaceutical preparations for the prevention of tauopathies; Pharmaceutical preparations for the treatment and prevention of tauopathies; Pharmaceutical preparations for the treatment of tauopathies; Pharmaceutical preparations for tauopathies;